AH

Adam D. Hughes

TI Theravance Biopharma R&D Ip: 11 patents #2 of 40Top 5%
TC Theravance Respiratory Company: 2 patents #1 of 8Top 15%
📍 Rue de l'Église, CA: #2 of 72 inventorsTop 3%
🗺 California: #608 of 60,411 inventorsTop 2%
Overall (2018): #4,052 of 503,207Top 1%
13
Patents 2018

Issued Patents 2018

Showing 1–13 of 13 patents

Patent #TitleCo-InventorsDate
10138220 Diamide compounds having muscarinic receptor antagonis and beta2 adrenergic receptor agonist activity Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more 2018-11-27
10130642 Neprilysin inhibitors Melissa Fleury, Roland Gendron 2018-11-20
10123984 Neprilysin inhibitors Erik Fenster, Melissa Fleury, Roland Gendron, Edmund J. Moran 2018-11-13
10100021 Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof Melissa Fleury, Miroslav Rapta, Venkat R. Thalladi, Gene Timothy Fass, Michael Simeone 2018-10-16
10053417 Neprilysin inhibitors Erik Fenster, Melissa Fleury 2018-08-21
10005740 Neprilysin inhibitors Melissa Fleury, Anne-Marie Beausoleil, Daniel D. Long, Donna A. A. Wilton 2018-06-26
9981999 Neprilysin inhibitors Melissa Fleury 2018-05-29
9975875 Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity Daniel H. Byun, Yan Chen, Melissa Fleury, John R. Jacobsen, Eric L. Stangeland +2 more 2018-05-22
9884807 Neprilysin inhibitors Melissa Fleury 2018-02-06
9873696 Neprilysin inhibitors Cameron Smith, Ryan Hudson 2018-01-23
9873685 Neprilysin inhibitors Melissa Fleury 2018-01-23
9872855 (2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid Melissa Fleury, Anne-Marie Beausoleil, Erik Fenster, Venkat R. Thalladi, Miroslav Rapta 2018-01-23
9868698 (2S,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-4-(ethoxyoxalylamino)-2-hydroxymethyl-2-methylpentanoic acid Erik Fenster, Melissa Fleury, Anne-Marie Beausoleil, Venkat R. Thalladi, Jerry Nzerem +1 more 2018-01-16